Brief: POINT Biopharma Global Reports Qtrly Results Ended June 30
Aug 12 (Reuters) - POINT Biopharma Global Inc PNT.O :
* POINT BIOPHARMA GLOBAL INC ANNOUNCES QTRLY RESULTS ENDED
JUNE 30
2022
* POINT BIOPHARMA GLOBAL INC - QTRLY LOSS PER SHARE OF $0.27
Source text: (https://bit.ly/3QgpEyq)
Further company coverage: PNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower